Brean Capital advice for Amgen
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| June 05, 2013 | Brean Capital | Amgen | Buy | 98.00 USD |
Advice details
New York - Op 05 Jun 2013 herhalen de analisten van Brean Capital hun koopadvies voor the American bio-technology company Amgen (ISIN: US0311621009 / Mnemo: AMGN). Het 12-maands koersdoel wordt opwaarts bijgesteld van 96.0 USD naar 98.0 USD.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 